E. coli

TD Vaccines A/S announced Jan. 25 the early results of a preliminary vaccine to combat a leading cause of bacterial diarrhea that afflicts millions of international travelers as well as children in the developing world.

Needle-free Vaccine

Intercell is offering free flights and hotel accommodation to 900 volunteers being recruited in the UK and Germany who are prepared to test a remedy for travelers’ diarrhea.

Patch-based Vaccine

LONDON and VIENNA — GlaxoSmithKline Biologicals and Intercell on Dec. 11 announced an agreement to form a strategic alliance to accelerate the development and commercialization of needle-free, patch-based vaccines.